GSK plc Files 6-K on Share Transaction
Ticker: GSK · Form: 6-K · Filed: Apr 17, 2026
Sentiment: neutral
Topics: share-transaction, 6-K, corporate-action
TL;DR
GSK bought back its own shares on 4/17/26. Details in 6-K.
AI Summary
GSK plc filed a Form 6-K on April 17, 2026, reporting a transaction in its own shares. The filing details a transaction involving GSK plc's own shares, with the company's registered address at 79 New Oxford Street, London, WC1A 1DG.
Why It Matters
This filing indicates GSK plc is actively managing its share capital, which could signal buybacks or other corporate actions affecting share count and potentially value.
Risk Assessment
Risk Level: low — This is a routine filing about share transactions and does not inherently indicate significant new risks.
Key Players & Entities
- GSK plc (company) — Filer of the 6-K report
- 0001131399 (company) — CIK number for GSK plc
- 2026-04-17 (date) — Period of report and filing date
- 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG (address) — Mailing and Business Address for GSK plc
FAQ
What type of transaction did GSK plc report in its 6-K filing?
GSK plc reported a 'TRANSACTION IN OWN SHARES' in its 6-K filing.
When was this 6-K filing submitted to the SEC?
The 6-K filing was submitted to the SEC on April 17, 2026.
What is GSK plc's CIK number?
GSK plc's CIK number is 0001131399.
Where is GSK plc's business address listed in the filing?
GSK plc's business address is listed as 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG.
What is the document type for accession number 0001654954-26-003629?
The document type is a 6-K filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 17, 2026 regarding GSK plc (GSK).